Clinical Trials Browser

Phase 2 × NIH × ixabepilone × Clear all

NCT00977574 2026-05-29

Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Phase 2 Active not recruiting

349 enrolled 11 charts

GynecologicSarcoma

Endometrial Adenocarcinoma

NCT00924066 2019-11-21

Ixabepilone to Treat Cervical Cancer

Phase 2 Terminated

41 enrolled 11 charts

Uterine Cervical Neoplasms

NCT01168232 2019-08-08

Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer

Phase 2 Completed

42 enrolled 10 charts

GynecologicSarcoma

Recurrent Uterine Corpus Sarcoma

NCT00025155 2019-07-24

Ixabepilone in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer That Has Not Responded to Previous Chemotherapy

Phase 2 Completed

51 enrolled 9 charts

Carcinoma, Ovarian Epithelial

NCT00095979 2019-07-24

Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer

Phase 2 Completed

52 enrolled 10 charts

Endometrial Neoplasms

NCT00923130 2018-04-17

Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer

Phase 2 Completed

30 enrolled 12 charts

Carcinoma, Renal Cell

NCT00058084 2017-02-23

Ixabepilone Compared With Mitoxantrone and Prednisone in Treating Patients With Refractory Metastatic Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT00022542 2015-04-15

BMS-247550 in Treating Patients With Advanced Soft Tissue Sarcoma

Phase 2 Terminated

Sarcoma

NCT00331643 2014-11-14

Ixabepilone in Treating Young Patients With Refractory Solid Tumors

Phase 2 Completed

CNSGenitourinarySarcoma

Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Osteosarcoma, Sarcoma, Synovial, Neuroectodermal Tumors, Primitive, Peripheral

NCT00079326 2014-06-02

Trastuzumab and Ixabepilone in Treating Women With HER2-Positive Metastatic Breast Cancer

Phase 2 Terminated

39 enrolled 8 charts

Breast Neoplasms

NCT00058019 2014-05-23

Ixabepilone in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Phase 2 Completed

51 enrolled 14 charts

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Mantle-Cell

NCT00077376 2014-05-21

Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer

Phase 2 Completed

61 enrolled 12 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00023946 2014-05-14

BMS-247550 in Treating Patients With Liver or Gallbladder Cancer

Phase 2 Terminated

Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular

NCT00087139 2014-05-09

Ixabepilone in Treating Patients With Metastatic Prostate Cancer

Phase 2 Completed

124 enrolled 10 charts

Prostatic Neoplasms

NCT00016393 2013-06-24

BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Phase 2 Completed

Prostatic Neoplasms

NCT00016965 2013-06-24

BMS-247550 in Treating Patients With Advanced Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT00052572 2013-06-24

Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative Disorders

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT00070096 2013-06-24

Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors

Phase 2 Completed

CNSGenitourinaryGynecologic

Testicular Germ Cell Tumor, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor

NCT00045097 2013-06-20

Ixabepilone in Treating Patients With Locally Advanced or Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT00182702 2013-03-25

Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney Cancer

Phase 2 Completed

Carcinoma, Renal Cell

NCT00033618 2013-02-27

Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck

Phase 2 Completed

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms

NCT00036764 2013-01-25

BMS-247550 in Treating Patients With Stage IV Melanoma

Phase 2 Completed

Melanoma

NCT00021099 2013-01-24

Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer

Phase 2 Completed

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT00030992 2012-08-20

BMS 247550 to Treat Kidney Cancer

Phase 2 Completed

102 enrolled 10 charts

Carcinoma, Renal Cell, Kidney Neoplasms